Gilead invests $5.1bn in Belgian biotech GalapagosBelgian biotech Galapagos has signed a shiny new deal with Gilead to develop inflammatory disease and rheumatoid arthritis Share XGilead invests $5.1bn in Belgian biotech Galapagoshttps://pharmaphorum.com/news/gilead-invests-5-1bn-in-belgian-biotech-galapagos/
Relief for GSK as Tesaro’s Zejula hits the mark in ovarian cancerGlaxoSmithKline raised eyebrows last year when it paid $5.1 billion for Tesaro and its PARP inhibitor Zejula, amid Share XRelief for GSK as Tesaro’s Zejula hits the mark in ovarian cancerhttps://pharmaphorum.com/news/relief-for-gsk-as-tesaros-zejula-hits-the-mark-in-ovarian-cancer/
German court blocks Sanofi’s cholesterol drug after Amgen lawsuitAmgen has lived up to its litigious reputation after it successfully persuaded a German court to uphold a Share XGerman court blocks Sanofi’s cholesterol drug after Amgen lawsuithttps://pharmaphorum.com/news/german-court-blocks-sanofis-cholesterol-drug-after-amgen-lawsuit/
Novartis trims again with $390m drugs sale to RecordatiNovartis has been streamlining its business since CEO Vas Narasimhan took over, and has continued that push with Share XNovartis trims again with $390m drugs sale to Recordatihttps://pharmaphorum.com/news/novartis-trims-again-with-390m-drugs-sale-to-recordati/
NICE recommends funding for psoriasis and type 1 diabetes drugsPatients in England and Wales should soon be able to access AbbVie’s psoriasis drug Skyrizi after NICE recommended Share XNICE recommends funding for psoriasis and type 1 diabetes drugshttps://pharmaphorum.com/news/nice-recommends-funding-for-psoriasis-and-type-1-diabetes-drugs/
Merck & Co and others test vaccine delivery droneMerck & Co is among the partners behind a consortium testing the potential to deliver temperature-controlled medicines and Share XMerck & Co and others test vaccine delivery dronehttps://pharmaphorum.com/news/merck-co-and-others-test-vaccine-delivery-drone/
Novartis and Amgen axe BACE drug for Alzheimer’sAnother Alzheimer’s disease drug has been axed after Novartis, Amgen and the Banner Alzheimer’s Institute decided to end Share XNovartis and Amgen axe BACE drug for Alzheimer’shttps://pharmaphorum.com/news/novartis-and-amgen-axe-bace-drug-for-alzheimers/
Karyopharm drug tested in ‘industry-first’ approach to brain cancerKaryopharm’s new drug Xpovio is to be tested in a new type of clinical trial designed to rapidly Share XKaryopharm drug tested in ‘industry-first’ approach to brain cancerhttps://pharmaphorum.com/news/karyopharm-drug-tested-in-industry-first-approach-to-brain-cancer/
Lilly dips as biomed chief Christi Shaw heads to GileadChristi Shaw, president of Eli Lilly Bio-Medicines is leaving the company after two years, taking the top job Share XLilly dips as biomed chief Christi Shaw heads to Gileadhttps://pharmaphorum.com/news/lilly-dips-as-biomed-chief-christi-shaw-heads-to-gilead/
Cello Health Insight launches in GermanyCello Health has opened for business in Germany with the launch of a new Berlin office and appointment Share XCello Health Insight launches in Germanyhttps://pharmaphorum.com/news/cello-health-germany-heike-tombrink/
Transgene begins trials of head and neck cancer vaccineVirus-based immunotherapy biotech Transgene is to begin clinical trials of its head and neck cancer drug candidate TG4050 Share XTransgene begins trials of head and neck cancer vaccinehttps://pharmaphorum.com/news/transgene-begins-trials-of-head-and-neck-cancer-vaccine/
Germany’s new law allows doctors to prescribe apps with health benefitsGermany has passed a law allowing doctors to prescribe digital apps with health benefits, which can be reimbursed Share XGermany’s new law allows doctors to prescribe apps with health benefitshttps://pharmaphorum.com/news/germanys-new-law-allows-doctors-to-prescribe-apps-with-health-benefits/
Scotland backs Pfizer’s Ibrance for breast cancerPfizer’s Ibrance has been approved for use by the NHS in Scotland as a second-line treatment for advanced Share XScotland backs Pfizer’s Ibrance for breast cancerhttps://pharmaphorum.com/news/scotland-backs-pfizers-ibrance-for-breast-cancer/
GSK hires former Genentech expert for AI unitGlaxoSmithKline has hired computational drug design specialist Dr Kim Branson to expand its artificial intelligence and machine learning Share XGSK hires former Genentech expert for AI unithttps://pharmaphorum.com/news/gsk-hires-former-genentech-expert-for-ai-unit/
FDA fast tracks Prevail’s Parkinson’s gene therapyThe FDA has fast tracked a gene therapy for a certain form of Parkinson’s Disease from US biotech Share XFDA fast tracks Prevail’s Parkinson’s gene therapyhttps://pharmaphorum.com/news/fda-fast-tracks-prevails-parkinsons-gene-therapy/
ViiV hails data showing switch from Truvada to two-drug HIV regimenViiV is continuing its assault on arch-rival Gilead in HIV, with phase 3 results aimed at giving doctors Share XViiV hails data showing switch from Truvada to two-drug HIV regimenhttps://pharmaphorum.com/news/viiv-hails-data-showing-switch-from-truvada-to-two-drug-hiv-regimen/
FDA reviews Sanofi’s multiple myeloma drug isatuximabThe FDA has begun its review of Sanofi’s multiple myeloma drug isatuximab, as the French pharma prepares for Share XFDA reviews Sanofi’s multiple myeloma drug isatuximabhttps://pharmaphorum.com/news/fda-reviews-sanofis-multiple-myeloma-drug-isatuximab/
Bayer may merge animal health unit with Elanco; reportBayer has delayed a planned sale of its animal health unit to private equity interests in order to Share XBayer may merge animal health unit with Elanco; reporthttps://pharmaphorum.com/news/bayer-may-merge-animal-health-unit-with-elanco-report/
Amgen on the role of RWE in a Product Evidence Generation Plan Share XAmgen on the role of RWE in a Product Evidence Generation Planhttps://pharmaphorum.com/partner-content/amgen-on-the-role-of-rwe-in-a-product-evidence-generation-plan/
4 Reasons Why Asia is the Next Hub of Microbiome Innovation Share X4 Reasons Why Asia is the Next Hub of Microbiome Innovationhttps://pharmaphorum.com/partner-content/4-reasons-why-asia-is-the-next-hub-of-microbiome-innovation/
13 Reasons to be a Part of SMi’s Cleanroom Technology Conference Share X13 Reasons to be a Part of SMi’s Cleanroom Technology Conferencehttps://pharmaphorum.com/partner-content/13-reasons-to-be-a-part-of-smis-cleanroom-technology-conference/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
